// healthcare technology

All signals tagged with this topic

Gene therapy enables remote control of brain cells to stop seizures

Chemogenetics—the ability to activate or suppress specific neurons using engineered genes and small molecules—has moved from animal models into human patients, with Chinese researchers reporting seizure reduction in three epilepsy cases. The shift from treating symptoms with pharmaceuticals to rewriting cellular behavior itself opens pathways for conditions like Parkinson's, depression, and chronic pain where precision neural modulation could replace broad-spectrum drugs. Stable patient compliance and delivery remain unsolved problems, but the clinical proof-of-concept signals that targeted brain intervention is moving from theoretical to viable.

Implanted electrode device removes glucose without drugs

Researchers have developed an electrocatalytic implant that metabolizes excess blood glucose directly, bypassing the pharmaceutical approach that dominates diabetes treatment. If validated in human trials, this shifts management from systemic drug delivery to localized electrochemical intervention—the model pacemakers use for cardiac rhythm. The stakes are significant for the 400+ million people with type 2 diabetes, though manufacturing, biocompatibility, and long-term electrode degradation remain unresolved engineering challenges before commercialization.